Pages that link to "Q27472768"

The following pages link to Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry (Q27472768):

Displaying 37 items.

• Hepatitis C virus proteins (Q24563969) (← links)
• Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I (Q24676039) (← links)
• Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virus (Q26783378) (← links)
• Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design (Q26801759) (← links)
• Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses (Q27473226) (← links)
• A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry (Q27477463) (← links)
• Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction (Q27477606) (← links)
• The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein (Q27481009) (← links)
• Expression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 Binding (Q27481026) (← links)
• Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry (Q27489898) (← links)
• Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles (Q27490271) (← links)
• Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization (Q27490466) (← links)
• Progress towards recombinant anti-infective antibodies (Q33568256) (← links)
• Within-host dynamics of the hepatitis C virus quasispecies population in HIV-1/HCV coinfected patients (Q33815695) (← links)
• Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies (Q33890011) (← links)
• Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy (Q34016463) (← links)
• Characterization of the envelope glycoproteins associated with infectious hepatitis C virus (Q34120689) (← links)
• Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteins (Q34540988) (← links)
• Phenotypic and genotypic differences between a child with vertically acquired severe hepatitis C liver disease and his mother (Q35622518) (← links)
• Spouse-to-Spouse Transmission and Evolution of Hypervariable Region 1 and 5' Untranslated Region of Hepatitis C Virus Analyzed by Next-Generation Sequencing (Q35936933) (← links)
• Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion (Q36318779) (← links)
• Characterization of hepatitis C virus recombinants with chimeric E1/E2 envelope proteins and identification of single amino acids in the E2 stem region important for entry (Q36559862) (← links)
• Hepatitis C virus entry: molecular biology and clinical implications (Q36581588) (← links)
• Recent advances in our understanding of receptor binding, viral fusion and cell entry of hepatitis C virus: new targets for the design of antiviral agents (Q36956517) (← links)
• Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems (Q37201846) (← links)
• Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance (Q37336496) (← links)
• Sequence and functional analysis of the envelope glycoproteins of hepatitis C virus variants selectively transmitted to a new host (Q37336742) (← links)
• CD81 and hepatitis C virus (HCV) infection. (Q37611819) (← links)
• Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation. (Q37864742) (← links)
• Type I interferon rapidly restricts infectious hepatitis C virus particle genesis. (Q38971183) (← links)
• The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus. (Q40087031) (← links)
• Structure-function analysis of hepatitis C virus envelope glycoproteins E1 and E2. (Q40189989) (← links)
• Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity. (Q40634075) (← links)
• Generation of infectious HCV pseudo typed particles and its utilization for studying the role of CD81 & SRBI receptors in HCV infection. (Q42227908) (← links)
• Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein (Q42720978) (← links)
• Evolution of hepatitis C virus hypervariable region 1 in chronically infected children. (Q42980510) (← links)
• A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism. (Q51149647) (← links)